Shandong Weigao Group Medical Polymer Company Limited (SHWGF)
USD 0.67
(0.0%)
USD 0.67
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.35 Billion USD | -2.56% |
| 2022 | 1.39 Billion USD | -6.04% |
| 2021 | 1.48 Billion USD | 7.5% |
| 2020 | 1.37 Billion USD | 3.0% |
| 2019 | 1.33 Billion USD | 4.82% |
| 2018 | 1.27 Billion USD | 167.33% |
| 2017 | 477.23 Million USD | -4.58% |
| 2016 | 500.13 Million USD | 22.52% |
| 2015 | 408.22 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.36 Billion USD | -0.65% |
| 2024 Q1 | 1.37 Billion USD | 1.23% |
| 2023 Q2 | 1.42 Billion USD | -5.48% |
| 2023 Q3 | 1.32 Billion USD | -7.0% |
| 2023 Q4 | 1.35 Billion USD | 2.28% |
| 2023 Q1 | 1.5 Billion USD | 8.39% |
| 2023 FY | 1.35 Billion USD | -2.56% |
| 2022 Q2 | 1.54 Billion USD | 0.0% |
| 2022 FY | 1.39 Billion USD | -6.04% |
| 2022 Q4 | 1.39 Billion USD | 0.8% |
| 2022 Q3 | 1.38 Billion USD | -10.41% |
| 2021 Q2 | 1.47 Billion USD | 0.0% |
| 2021 FY | 1.48 Billion USD | 7.5% |
| 2021 Q4 | 1.47 Billion USD | 0.0% |
| 2020 FY | 1.37 Billion USD | 3.0% |
| 2020 Q4 | 1.35 Billion USD | 0.0% |
| 2019 Q2 | 1.28 Billion USD | 0.0% |
| 2019 Q4 | 1.33 Billion USD | 0.0% |
| 2019 FY | 1.33 Billion USD | 4.82% |
| 2018 FY | 1.27 Billion USD | 167.33% |
| 2018 Q4 | 1.27 Billion USD | 0.0% |
| 2017 FY | 477.23 Million USD | -4.58% |
| 2016 FY | 500.13 Million USD | 22.52% |
| 2015 FY | 408.22 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -57593.454% |
| Ansell Limited | 1.32 Billion USD | -1.94% |
| Ansell Limited | 1.33 Billion USD | -1.749% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -973.081% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -143639.018% |
| Psykey, Inc. | 2.47 Million USD | -54697.727% |
| ConvaTec Group Plc | 2.01 Billion USD | 32.824% |
| ConvaTec Group Plc | 2.02 Billion USD | 32.919% |
| Encision Inc. | 1.98 Million USD | -68233.067% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -44488.572% |
| Innovative MedTech Inc. | 6.13 Million USD | -21998.466% |
| LifePoint, Inc. | 2.45 Million USD | -55140.946% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -13216.041% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -39773.711% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -44490.86% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -174530.366% |
| SmileDirectClub, Inc. | 982.26 Million USD | -38.019% |
| Sector 10, Inc. | 9.84 Million USD | -13669.906% |
| SheerVision, Inc. | 1.43 Million USD | -94611.704% |
| United Health Products, Inc. | 1.99 Million USD | -67723.663% |
| Vasamed, Inc. | 1 Million USD | -134755.881% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -35573.803% |
| Yubo International Biotech Limited | 2.91 Million USD | -46425.104% |